NEW YORK, June 4, 2012 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: <\/p>\n
Leading Anti-Cancer Drugs and Associated Market 2012-2022 <\/p>\n
http:\/\/www.reportlinker.com\/p0819459\/Leading-Anti-Cancer-Drugs-and-Associated-Market-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication<\/a> <\/p>\n Report Details <\/p>\n Cancer treatments - discover which products have greatest potential <\/p>\n Where are cancer-treating drugs heading? Visiongain's report shows you potential revenues to 2022, with data, forecasts and discussions. <\/p>\n This study investigates leading drugs to treat human cancers. It lets you assess potential sales trends at world market, therapeutic submarket, product and national level to 2022. <\/p>\n How will 25 leading products - including Avastin, Rituxan, Herceptin and Glivec\/Gleevec - perform from 2012? See potential revenues and other information. The study also assesses eight recently approved drugs. <\/p>\n Our investigation gives you business research and analysis with sales forecasts. You also see forecasting of five submarkets to 2022, finding potential revenues: <\/p>\n Traditional antineoplastic agents <\/p>\n<\/p>\n Read more here: NEW YORK, June 4, 2012 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Leading Anti-Cancer Drugs and Associated Market 2012-2022 http:\/\/www.reportlinker.com\/p0819459\/Leading-Anti-Cancer-Drugs-and-Associated-Market-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication<\/a> Report Details Cancer treatments - discover which products have greatest potential Where are cancer-treating drugs heading? Visiongain's report shows you potential revenues to 2022, with data, forecasts and discussions. This study investigates leading drugs to treat human cancers. Continue reading
\nLeading Anti-Cancer Drugs and Associated Market 2012-2022<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"